Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-10

FDA Approved: NEOSTIGMINE — Original Application (Dr.Reddy's Laboratories Inc)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' original application for neostigmine, a generic acetylcholinesterase inhibitor used to treat myasthenia gravis and to rev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine (neostigmine)

Snippet

ORIG AP for NEOSTIGMINE (NEOSTIGMINE)